C-Phycocyanin prevents acute myocardial infarction-induced oxidative stress, inflammation and cardiac damage

Pharm Biol. 2022 Dec;60(1):755-763. doi: 10.1080/13880209.2022.2055089.

Abstract

Context: C-Phycocyanin is a protein with anti-scavenger, antioxidant and anti-inflammatory actions against agents that cause cellular damage. The cardioprotective action of C-phycocyanin against acute myocardial infarction (AMI) has not been studied in animal models.

Objective: To investigate C-phycocyanin's effect on oxidative stress, inflammation and cardiac damage in a model of isoproterenol-induced AMI.

Materials and methods: Wistar rats were divided into four groups: (1) sham + vehicle (0.9% saline solution by oral gavage, OG); (2) sham + C-phycocyanin (50 mg/kg/d, OG); (3) AMI + vehicle, and (4) AMI + C-phycocyanin. AMI was induced by administering isoproterenol (20, 10, 5 and 3 mg/kg each dose per day), and serum cardiac enzymes were quantified. After five days, the animals were euthanized; the heart was dissected to determine oxidative stress, redox environment, inflammation and cardiac damage markers.

Results: We observed that C-phycocyanin reduced AMI-increased cardiac enzymes (CK by about 53%, CKMB by about 60%, AST by about 16% and ALT by about 21%), lipid peroxidation (57%), reactive oxygen species (50%), nitrites (46%), oxidized glutathione (41%), IL1β (3%), INFγ (5%), TNFα 3%), Bcl2 (37%), Bax (43%), COX2 (21%) and caspase 9 (61%). Finally, C-phycocyanin reduced AMI-induced aberrant histological changes related to myonecrosis, interstitial oedema and inflammatory infiltration in the heart muscle.

Conclusions: C-Phycocyanin prevents AMI-induced oxidative stress, inflammation and heart damage. This study is the first report that employed C-phycocyanin in an animal model of AMI and supports the potential use of C-phycocyanin in the management of AMI.

Keywords: Phycobiliproteins; anti-inflammatory; cardioprotection; cardiotoxicity; heart damage.

MeSH terms

  • Animals
  • Inflammation / drug therapy
  • Inflammation / prevention & control
  • Myocardial Infarction* / pathology
  • Myocardial Infarction* / prevention & control
  • Oxidative Stress
  • Phycocyanin* / adverse effects
  • Phycocyanin* / metabolism
  • Rats
  • Rats, Wistar

Substances

  • Phycocyanin

Grants and funding

This study is supported by SIP-IPN (20210052, 20210080, 20210743 and 20210787). We thank Instituto Politécnico Nacional, Secretaría de Investigación y Posgrado-IPN, for financial support.